fluoxetine

You have access
Fluoxetine Suppresses Osteosarcoma Progression In Vivo by Inducing Apoptosis and Inhibiting the AKT/mTOR/NF-κB Signaling Pathway
YU-HSI CHEN, CHI-HUAN LI, SHIH-WEI LIU, FEI-TING HSU and MING-CHOU KU

Anticancer Research April 2025, 45 (4) 1465-1480; DOI: https://doi.org/10.21873/anticanres.17530
You have access
Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells
WEI-TING CHEN, YUAN-HSIN TSAI, PEGGY TAN, FEI-TING HSU, HUI-MIN DAVID WANG, WEI-CHIN LIN, FENG-HUEI LIN and CHING-TE WU

Anticancer Research March 2023, 43 (3) 1193-1199; DOI: https://doi.org/10.21873/anticanres.16265
You have access
STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo
PEN-AN LIAO, PEI-YI CHU, ZHAO-LIN TAN, FEI-TING HSU, YANG-CHENG LEE and HSING-JU WU

Anticancer Research August 2022, 42 (8) 3807-3814; DOI: https://doi.org/10.21873/anticanres.15871
You have access
Fluoxetine Inhibits DNA Repair and NF-ĸB-modulated Metastatic Potential in Non-small Cell Lung Cancer
JENG-YUAN WU, SONG-SHEI LIN, FEI-TING HSU and JING-GUNG CHUNG

Anticancer Research September 2018, 38 (9) 5201-5210; DOI: https://doi.org/10.21873/anticanres.12843
You have access
Fluoxetine-induced Apoptosis in Hepatocellular Carcinoma Cells
A-REUM MUN, SEI-JIN LEE, GI-BEUM KIM, HYUNG-SUB KANG, JIN-SHANG KIM and SHANG-JIN KIM

Anticancer Research September 2013, 33 (9) 3691-3697;

Main menu